Mirum Pharmaceuticals Inc (MIRM)

Mirum Pharmaceuticals Inc Azioni (MIRM) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	0.48% 69.22	69.55	47.73	37.50	31.60
Operating Expenses	6.31% 95.69	102.14	72.87	61.77	58.75
Benefits Costs and Expenses	10.58% 93.88	104.99	71.06	111.22	61.53
Costs And Expenses	10.58% 93.88	104.99	71.06	111.22	61.53
Operating Income/Loss	18.77% -26.47	-32.59	-25.15	-24.27	-27.15
Income/Loss From Continuing Operations Before Tax	30.42% -24.66	-35.43	-23.34	-73.72	-29.93
Income Tax Expense/Benefit	177.33% 0.624	0.225	0.249	0.316	0.201
Income/Loss From Continuing Operations After Tax	29.11% -25.28	-35.66	-23.59	-74.04	-30.13
Net Income/Loss	29.11% -25.28	-35.66	-23.59	-74.04	-30.13
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,354% 46.93	1.9121	41.10	38.11	37.68
Diluted Average Shares	2,354% 46.93	1.9121	41.10	38.11	37.68
Basic Earnings Per Share	25.00% -0.54	-0.72	-0.57	-1.94	-0.80
Diluted Earnings Per Share	25.00% -0.54	-0.72	-0.57	-1.94	-0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-